AI ECG Algorithm for Detecting LV Systolic Dysfunction
Prospective Observational Cohort Study of Deep Learning-based ECG Algorithm for Detecting Left Ventricular Systolic Dysfunction
1 other identifier
observational
15,000
1 country
1
Brief Summary
This prospective observational cohort study aims to evaluate the clinical performance of a deep learning-based electrocardiography (ECG) algorithm (DeepECG LVSD) for detecting left ventricular systolic dysfunction (LVSD), defined as left ventricular ejection fraction (LVEF) ≤40%, using transthoracic echocardiography as the reference standard. Approximately 15,000 adult patients undergoing both ECG and echocardiography within 30 days at Ajou University Hospital will be enrolled. Diagnostic performance will be assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. Secondary analyses will evaluate the association between AI-predicted LVSD and 30-day clinical outcomes, including all-cause mortality, emergency department visits, and heart failure rehospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 4, 2026
CompletedFirst Posted
Study publicly available on registry
June 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 10, 2026
June 1, 2026
2 years
June 4, 2026
June 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AUROC for detection of LVSD (LVEF ≤40%)
Diagnostic performance including AUROC, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.
During procedure
Study Arms (1)
Adults aged ≥19 years with ECG and echocardiography performed within 30 days
Adult patients aged 19 years or older who underwent both transthoracic echocardiography and electrocardiography (ECG) within 30 days of each other
Interventions
There is no intervention group
Eligibility Criteria
Adult patients aged 19 years or older undergoing routine clinical care at Ajou University Hospital who have both transthoracic echocardiography and 12-lead electrocardiography (ECG) performed within 30 days. Participants may be recruited from outpatient clinics, inpatient wards, or the emergency department.
You may qualify if:
- Adults aged ≥19 years.
- Patients who underwent both transthoracic echocardiography and 12-lead electrocardiography (ECG) at Ajou University Hospital in the outpatient, inpatient, or emergency department setting.
- ECG and echocardiography performed within 30 days of each other.
You may not qualify if:
- Interval between ECG and echocardiography greater than 30 days.
- Missing or corrupted original ECG waveform data (XML or HL7 format).
- Presence of an implanted cardiac device, including a permanent pacemaker, implantable cardioverter-defibrillator (ICD), or cardiac resynchronization therapy (CRT) device.
- Missing age, sex, or left ventricular ejection fraction (LVEF) data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ajou University School of Medicinelead
- VUNO Inc.collaborator
Study Sites (1)
Ajou University School of Medicine
Suwon, Gyeonggi-do, 16499, South Korea
Related Publications (3)
Lopez-Jimenez F, Alger HM, Attia ZI, Barry B, Chatterjee R, Dolor R, Friedman PA, Greene SJ, Greenwood J, Gundurao V, Hackett S, Jain P, Kinaszczuk A, Mehta K, O'Grady J, Pandey A, Pullins C, Puranik AR, Ranganathan MK, Rushlow D, Stampehl M, Subramanian V, Vassor K, Zhu X, Awasthi S. A multicenter pragmatic implementation study of AI-ECG-based clinical decision support software to identify low LVEF: Clinical trial design and methods. Am Heart J Plus. 2025 Mar 21;54:100528. doi: 10.1016/j.ahjo.2025.100528. eCollection 2025 Jun.
PMID: 40276542RESULTChoi J, Lee S, Chang M, Lee Y, Oh GC, Lee HY. Author Correction: Deep learning of ECG waveforms for diagnosis of heart failure with a reduced left ventricular ejection fraction. Sci Rep. 2022 Oct 13;12(1):17191. doi: 10.1038/s41598-022-22012-7. No abstract available.
PMID: 36229570RESULTAttia ZI, Kapa S, Lopez-Jimenez F, McKie PM, Ladewig DJ, Satam G, Pellikka PA, Enriquez-Sarano M, Noseworthy PA, Munger TM, Asirvatham SJ, Scott CG, Carter RE, Friedman PA. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med. 2019 Jan;25(1):70-74. doi: 10.1038/s41591-018-0240-2. Epub 2019 Jan 7.
PMID: 30617318RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 4, 2026
First Posted
June 9, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
June 10, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared due to patient privacy and institutional data protection policies.